Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | NOS3 | P29474 | 3/20 | 0.42 |
| ▸ | NOS1 | P29475 | 3/20 | 0.42 |
| ▸ | NOS2 | P35228 | 3/20 | 0.42 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11227844 | 0.97 | CYP1A2 (0.70) | CYP1A2SIGMAR1CA1CA2CA4 | |
| SCHEMBL7738781 | 0.97 | CYP1A2 (0.70) | CYP1A2SIGMAR1CA1CA2CA4 | |
| SCHEMBL27988307 | 0.97 | CYP1A2 (0.70) | CYP1A2SIGMAR1CA1CA2CA4 | |
| SCHEMBL7741556 | 0.97 | CYP1A2 (0.70) | CYP1A2SIGMAR1CA1CA2CA4 | |
| SCHEMBL11726232 | 0.97 | CYP1A2 (0.70) | CYP1A2SIGMAR1CA1CA2CA4 | |
| SCHEMBL97288 | 0.97 | CYP1A2 (0.70) | CYP1A2SIGMAR1CA1CA2CA4 | |
| SCHEMBL3633846 | 0.97 | CYP1A2 (0.70) | CYP1A2SIGMAR1CA1CA2CA4 | |
| SCHEMBL905661 | 0.97 | CYP1A2 (0.70) | CYP1A2SIGMAR1CA1CA2CA4 | |
| SCHEMBL128915 | 0.97 | — | — | |
| Ammonia Solution, Strong SCHEMBL2254142 | 0.94 | CYP1A2 (0.67) | CYP1A2SIGMAR1CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9783474-B2 | Catalytic biomass conversion methods, catalysts, and methods of making the same | PURDUE RESEARCH FOUNDATION (US) | 2017-10-10 | — | — | US | disclosed |
| US-20160289150-A1 | CATALYTIC BIOMASS CONVERSION METHODS, CATALYSTS, AND METHODS OF MAKING THE SAME | PURDUE RESEARCH FOUNDATION (US) | 2016-10-06 | — | — | US | disclosed |
| US-20160272665-A1 | PRODUCTION OF RENEWABLE FINE CHEMICALS AND LIQUID FUELS | PURDUE RESEARCH FOUNDATION (US) | 2016-09-22 | — | — | US | disclosed |
| EP-3060718-A1 | CATALYTIC BIOMASS CONVERSION METHODS, CATALYSTS, AND METHODS OF MAKING THE SAME | Purdue Research Foundation (US) | 2016-08-31 | — | — | EP | disclosed |
| WO-2015061804-A1 | PRODUCTION OF RENEWABLE FINE CHEMICALS AND LIQUID FUELS | PURDUE RESEARCH FOUNDATION (US) | 2015-04-30 | — | — | WO | disclosed |
| WO-2015061802-A1 | CATALYTIC BIOMASS CONVERSION METHODS, CATALYSTS, AND METHODS OF MAKING THE SAME | PURDUE RESEARCH FOUNDATION (US) | 2015-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160289150-A1 | CATALYTIC BIOMASS CONVERSION METHODS, CATALYSTS, AND METHODS OF MAKING THE SAME | HAO2, HPD, HAAO | CYP1A2 169/4885SIGMAR1 3380/4885CA1 1124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.